Repligen (RGEN) Stock Price & Financial Analysis
Repligen Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Repligen
What is the current stock price for RGEN?
As of the latest trading session, RGEN stock trades at $117.78. The 52-week range is $102.97–$175.77, with a day range of $114.20–$121.72.
What is the P/E ratio for RGEN?
Repligen's trailing P/E ratio is 136.9, meaning investors pay $136.9 for every $1 of annual earnings. Repligen operates in the Healthcare sector.
Does RGEN pay dividends?
Repligen does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for RGEN?
Based on 5 analysts, the consensus for RGEN is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of RGEN?
Repligen's market capitalization is $6.66B, classifying it as a mid-cap company. Repligen operates in the Healthcare sector within the Medical Instruments & Supplies industry.